Bangladesh vs Least Developed Countries (LDCs): Proportion of the target population who received a 3rd dose of
Bangladesh
97.0%
in 2024
Least Developed Countries (LDCs)
69.0%
in 2024
Bangladesh rank
11th
Least Developed Countries (LDCs) rank
21st
Proportion of the target population who received a 3rd dose of over time
- Bangladesh
- Least Developed Countries (LDCs)
How they compare
Bangladesh currently reports 97.0% against 69.0% in Least Developed Countries (LDCs), a difference of 28.0%.
That makes Bangladesh's figure about 1.4 times Least Developed Countries (LDCs)'s.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Least Developed Countries (LDCs) ahead.
Bangladesh ranks 11th and Least Developed Countries (LDCs) ranks 21st of 157 countries.
Bangladesh has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Least Developed Countries (LDCs) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.2% | 69.8% | 18.4% | Bangladesh |
| 2020s | 97.4% | 69.0% | 28.4% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Bangladesh or Least Developed Countries (LDCs)?
- Bangladesh, at 97.0% against 69.0% in Least Developed Countries (LDCs) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Bangladesh and Least Developed Countries (LDCs)?
- 28.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Least Developed Countries (LDCs)?
- 10 years are reported by both, from 2015 to 2024.
- How do Bangladesh and Least Developed Countries (LDCs) rank globally for proportion of the target population who received a 3rd dose of?
- Bangladesh ranks 11th and Least Developed Countries (LDCs) ranks 21st of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.